ARNALDI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 415
EU - Europa 144
AS - Asia 116
SA - Sud America 3
AF - Africa 1
Totale 679
Nazione #
US - Stati Uniti d'America 415
SG - Singapore 96
DE - Germania 57
IT - Italia 40
CN - Cina 11
GB - Regno Unito 8
FR - Francia 7
IE - Irlanda 6
FI - Finlandia 5
PL - Polonia 4
TR - Turchia 4
PE - Perù 3
RO - Romania 3
RU - Federazione Russa 3
UA - Ucraina 3
GR - Grecia 2
IN - India 2
NL - Olanda 2
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
IQ - Iraq 1
JP - Giappone 1
LT - Lituania 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 679
Città #
Fairfield 63
Singapore 54
Ashburn 47
Ludwigshafen am Rhein 39
Chandler 35
Seattle 28
Woodbridge 27
Wilmington 26
Cambridge 23
Ann Arbor 19
Houston 17
Palermo 11
Council Bluffs 10
Des Moines 8
Falls Church 8
Medford 8
Altamura 7
San Diego 7
West Jordan 7
Dublin 6
Lawrence 6
Princeton 6
London 5
Rome 5
Dearborn 4
Helsinki 4
Izmir 4
Krefeld 4
Nuremberg 4
Boardman 3
Guangzhou 3
Milan 3
Norwalk 3
Amsterdam 2
Athens 2
Clifton 2
Dottingen 2
Dragoni 2
Hebei 2
Hefei 2
Iquitos 2
Kitzingen 2
Piscataway 2
Redwood City 2
Tulsa 2
Warsaw 2
Xi'an 2
Abidjan 1
Bad Bellingen 1
Brussels 1
Castel San Lorenzo 1
Frankfurt am Main 1
Halle 1
Jinan 1
Kiev 1
Kilburn 1
Kumar 1
Las Vegas 1
Lima 1
Oakland 1
Padova 1
Pune 1
Saint Petersburg 1
San Paolo di Civitate 1
Sofia 1
Tappahannock 1
Tianjin 1
Tokyo 1
Vilnius 1
Wandsworth 1
Totale 555
Nome #
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome 170
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 103
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 86
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 67
Glucocorticoid excess and COVID-19 disease 46
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors 21
Adrenal incidentaloma 19
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 18
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas 18
Pathophysiology of dyslipidemia in Cushing's syndrome 16
Italian addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency 16
Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma 15
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 15
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia 15
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 15
Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome 15
Psychometric properties of the Italian version of the Revised Temperament and Character Inventory (TCI-140) in adults and older adults with cancer managed in outpatient settings 14
Investigation protocol: adrenal enlargement 14
Variable expression of the transcription factors cAMP response element-binding protein and inducible cAMP early repressor in the normal adrenal cortex and in adrenocortical adenomas and carcinomas 13
Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status 13
A venous thromboembolism risk assessment model for patients with Cushing's syndrome 13
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies 13
Mutational analysis of StAR gene in adrenal tumors 13
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications 12
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study 12
Pegvisomant in acromegaly: why, when, how 12
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart 12
Laurdan fluorescence: a simple method to evaluate sperm plasma membrane alterations 12
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 12
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly 12
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations 12
New treatment guidelines on Cushing's disease 12
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 11
Endocrinologists at work: management of hyponatremia in clinical practice 10
Diabetes Insipidus: Novel Diagnostic Approaches 10
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 10
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 10
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas 10
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY 10
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation 10
Self image and quality of life in acromegaly 10
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 10
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study 10
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 9
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease 9
Fracture risk assessment before and after resolution of endogenous hypercortisolism: is the FRAX® algorithm useful? 9
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 9
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 9
Apparent mineralocorticoid excess type II 9
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 9
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 9
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 9
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 8
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2) 8
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis 8
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 8
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 8
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay 8
Hypertension due to renal artery occlusion in a patient with antiphospholipid syndrome 8
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 8
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 8
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 8
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study 8
Using temperament and character dimensions (TCI) to analyze the personality profiles of adults and older adults with cancer managed in outpatient settings 8
Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia 8
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles 8
Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman's syndrome 8
Acromegalia e Ancona: un fil rouge lungo trecento anni, da Amato Lusitano ad Augusto Tamburini 7
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 7
Approach to the patient with possible Cushing's syndrome 7
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 7
Intrapituitary cytokines in Cushing's disease: do they play a role? 7
How to improve effectiveness of pegvisomant treatment in acromegalic patients 7
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines 7
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 7
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 7
Pasireotide for the treatment of Cushing's disease 7
Osilodrostat oral tablets for adults with Cushing's disease 7
Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors 7
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma 7
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor 7
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 7
Coagulopathy in Cushing's syndrome 7
Targeting Estrogen Receptor-α Reduces Adrenocortical Cancer (ACC) Cell Growth in Vitro and in Vivo: Potential Therapeutic Role of Selective Estrogen Receptor Modulators (SERMs) for ACC Treatment 7
Advances in medical treatment of Cushing’s disease 7
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation 6
Diagnosis and complications of Cushing's syndrome: a consensus statement 6
Acromegaly and male sexual health 6
Structural Analysis of Social Behavior: Using Cluster Analysis to Examine Intrapsychic Personality Traits Associated With Depression in Women With Breast Cancer 6
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome 6
An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options? 6
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 6
null 6
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Totale 1.363
Categoria #
all - tutte 7.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020120 5 7 5 19 9 13 8 9 17 7 13 8
2020/2021109 8 4 9 1 13 19 4 9 4 7 22 9
2021/202291 6 10 6 2 7 8 9 4 13 8 6 12
2022/2023102 14 21 2 11 10 14 5 6 13 0 3 3
2023/2024807 1 8 1 1 1 210 305 17 5 11 217 30
2024/2025101 101 0 0 0 0 0 0 0 0 0 0 0
Totale 1.371